We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+21.25%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$128M
AUM Growth
–
Cap. Flow
+$121M
Cap. Flow %
95.08%
Top 10 Hldgs %
56.2%
Holding
52
New
52
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$11.6M
2
CALX icon
Calix
CALX
+$10.1M
3
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$6.92M
4
LSAK icon
Lesaka Technologies
LSAK
+$6.86M
5
BEAT
BioTelemetry, Inc.
BEAT
+$6.55M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 45.91%
2 Technology 33.09%
3 Materials 4.86%
4 Miscellaneous 4.56%
5 Communication Services 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEAT
1
DELISTED
BioTelemetry, Inc.
BEAT
$11.5M 9%
+1,945,672
New +$6.55M
CALX icon
2
Calix
CALX
$2.37B
$11M 8.59%
+1,084,206
New +$10.1M
MSTR icon
3
Strategy Inc
MSTR
$54.6B
$10.8M 8.49%
+1,244,630
New +$11.6M
LSAK icon
4
Lesaka Technologies
LSAK
$391M
$6.98M 5.48%
+948,566
New +$6.86M
TLPH icon
5
Talphera
TLPH
$63.8M
$6.79M 5.33%
+36,645
New +$5.23M
BDSI
6
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$5.99M 4.7%
+1,474,906
New +$6.92M
SANW
7
DELISTED
S&W Seed Co
SANW
$5.12M 4.01%
+32,132
New +$5.37M
RPRX
8
DELISTED
Repros Therapeutics Inc.
RPRX
$4.89M 3.84%
+265,300
New +$4.69M
SIGA icon
9
SIGA Technologies
SIGA
$220M
$4.46M 3.49%
+1,568,937
New +$5.26M
UI icon
10
Ubiquiti
UI
$35.9B
$4.17M 3.27%
+237,963
New +$3.92M
MEET
11
DELISTED
The Meet Group, Inc. Common Stock
MEET
$3.94M 3.09%
+2,417,959
New +$4.25M
PKT
12
DELISTED
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
$3.75M 2.94%
+273,000
New +$3.52M
CSII
13
DELISTED
Cardiovascular Systems, Inc.
CSII
$3.74M 2.93%
+176,341
New +$3.43M
ZLTQ
14
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$3.73M 2.92%
+583,218
New +$2.77M
PCYO icon
15
Pure Cycle
PCYO
$275M
$3.19M 2.51%
+571,384
New +$3.4M
VSTM icon
16
Verastem
VSTM
$668M
$3.1M 2.43%
+18,587
New +$2.24M
SMSI icon
17
Smith Micro Software
SMSI
$16.5M
$2.99M 2.35%
+17,651
New +$3.64M
COA
18
DELISTED
COASTAL CONTACTS INC COMMON SHARES (CANADA)
COA
$2.89M 2.26%
+560,464
New +$3.18M
ASPS icon
19
Altisource Portfolio Solutions
ASPS
$63.7M
$2.4M 1.88%
+3,175
New +$2.22M
SRL icon
20
Scully Royalty
SRL
$88.9M
$2.3M 1.8%
+57,000
New +$2.39M
ARAY icon
21
Accuray
ARAY
$31.3M
$2M 1.57%
+347,766
New +$1.76M
IPXL
22
DELISTED
Impax Laboratories, Inc.
IPXL
$1.8M 1.41%
+90,400
New +$1.6M
FBIO icon
23
Fortress Biotech
FBIO
$93.4M
$1.59M 1.25%
+12,300
New +$1.81M
SDEV
24
Stablecoin Development Corp
SDEV
$49.5M
$1.51M 1.18%
+7
New +$1.49M
OPTR
25
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
$1.45M 1.14%
+100,500
New +$1.46M
1
2 3

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Sophrosyne Capital, which disclosed 52 positions worth $128M. Its ten largest holdings account for 56% of the portfolio.

Its largest position is Strategy Inc: 1,244,630 shares worth $10.8M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, followed by Technology and Materials.

  • Sophrosyne Capital's largest Q2 2013 buy was Strategy Inc: 1,244,630 shares worth $10.8M.
  • Sophrosyne Capital's ten largest holdings make up 56% of its $128M portfolio in Q2 2013.
  • Sophrosyne Capital disclosed 52 positions in Q2 2013, its first 13F filing on record.

Based on Sophrosyne Capital's 13F filing for Q2 2013, filed 14 Aug 2013.